A different approach to treating demodex blepharitis
January 3rd 2014You see them year after year in your chair: persistent cylindrical dandruff (CD), red lid margins, and eyelash distention. You've prescribed lid scrubs with baby shampoo, warm compresses, and even steroid/antibiotic combo drops, but nothing seems to resolve the condition. If this is the case, it's likely you are dealing with demodex blepharitis.
IOP as a cornerstone to glaucoma management
January 2nd 2014The measurement and management of intraocular pressure (IOP) in patients with glaucoma is critical. Even with the onslaught of new technologies to monitor progression and make earlier diagnoses, IOP remains a crucial data point in the optometric examination.
Prevent Blindness declares January National Glaucoma Awareness Month
December 30th 2013Prevent Blindness and other eye health organizations have declared January as National Glaucoma Awareness Month. Prevent Blindness seeks to educate the public on the second leading cause of blindness, following cataracts, by providing free resources via online or by mail through its Glaucoma Learning Center.
Opinion: The unintended consequences of optometric board certification
December 30th 2013The NBEO has made both an obvious and a very courageous decision to embrace its certification as board certification in general optometry. Obvious in that more than 10,000 ODs already represent themselves to be board certified by the NBEO to the Council for Affordable Quality Healthcare (CAQH) and subsequently to the health plans that rely on CAQH for credentialing. And it was courageous, as I’m certain the NBEO faced opposition to its action.
Understanding the strengths and weaknesses of different solutions
December 26th 2013Many patients may assume their solution of choice will do the job and that, perhaps, the differences represented on the shelf are minimal. But we know that contact lens solutions are complex formulations of biocides, buffering agents, and surfactants, and that the balance between these agents must be nearly perfect.
QLT begins IDA proof-of-concept trial
December 23rd 2013QLT Inc. announced that the first patient has been dosed in the company's Phase IIa proof-of-concept trial of QLT091001 in adult subjects with impaired dark adaptation (IDA), a condition that results in decreased ability to recover visual sensitivity in the dark after exposure to bright lights.
Preoperative considerations in patients with cataracts and pseudoexfoliation syndrome
December 20th 2013Preoperative evaluation of patients with pseudoexfoliation (PXF) syndrome is essential in preparing for and potentially preventing complications during phacoemulsification. Patients with PXF have been documented to have an accelerated rate of cataracts, both nuclear and subcapsular.